NovaBridge Biosciences American Depositary Shares
NBP
119 hedge funds and large institutions have $657M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 21 reducing their positions, and 29 closing their positions.
176% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 21
0.31% more ownership
Funds ownership: 50.12% → 50.43% (+0.31%)
10% less funds holding
Funds holding: 132 → 119 (-13)
36% less call options, than puts
Call options by funds: $3.45M | Put options by funds: $5.36M
41% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 29
50% less funds holding in top 10
Funds holding in top 10: 10 → 5 (-5)
65% less capital invested
Capital invested by funds: $1.85B → $657M (-$1.2B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$26M |
| 2 |
BlackRock
New York
|
+$24.1M |
| 3 |
IAMH
IvyRock Asset Management (HK)
Sheung Wan,
Hong Kong
|
+$15.7M |
| 4 |
Two Sigma Investments
New York
|
+$10.7M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$50.1M |
| 2 |
ZAM
Zeal Asset Management
Central,
Hong Kong
|
-$30.5M |
| 3 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$17.8M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$13.7M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$8.29M |
NBP Hedge Fund Activity: Q1 2022 in Review
119 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2022, worth a combined $657M — down 65% from $1.85B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of NBP and 17 opened new positions — a net loss of 12 holders — while 21 trimmed existing stakes and 58 added.
The largest buyer was Artisan Partners, adding an estimated $26M. The largest seller was T. Rowe Price Associates, cutting an estimated $50.1M.
- 119 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2022, down from 132 in Q4 2021.
- Funds reported $657M of NovaBridge Biosciences American Depositary Shares stock for Q1 2022, down 65% quarter-over-quarter.
- 17 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2022 and 29 closed out, a net change of -12 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2022 was Artisan Partners, an estimated $26M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2022 was T. Rowe Price Associates, an estimated $50.1M sold.
Based on aggregated 13F filings for Q1 2022.